Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HFBL vs CBAN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HFBL Captures Overall Composite Edge (61.3 BUY vs 44.9 HOLD), While CBAN Leads 4–1 on Growth & Valuation Pillars

HFBL Overall Winner 6-Pillar Tally: HFBL 1 – 4 CBAN (1 Tie) Matrix Metrics: HFBL 5 – 5 CBAN

As of Nov 16, 2026, Home Federal Bancorp, Inc. of Louisiana (HFBL) captures the overall head-to-head institutional edge over Colony Bankcorp Inc. (CBAN) on higher Unified Composite conviction (61.3/100 BUY vs. 44.9/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality), while CBAN wins 4–1 across the 6-pillar growth and valuation breakdown. HFBL trades at $24.19 (11.8x Forward P/E, 37.1% operating margin) versus CBAN at $20.18 (8.4x Forward P/E, 33.4% operating margin).

  • Growth vs. Quality Trade-Off: HFBL earns the overall head-to-head edge with a stronger Unified Composite Score (61.3/100 BUY vs. CBAN 44.9/100 HOLD) and 0.00β · 81% Vol risk profile, whereas CBAN leads top-line expansion (+26.0% YoY revenue growth, 2.11x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: HFBL trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.4); meanwhile CBAN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HFBL vs CBAN
HFBL NASDAQ Head-to-Head Winner
Home Federal Bancorp, Inc. of Louisiana
Savings Institution, Federally Chartered
$24.19
+1.0% 1D
Market Cap $71.8M
TTM Revenue $24M
Forward P/E 11.8x
Beta / 30D Vol 0.00β · 81% Vol
Unified Composite Score
61.3 / 100 BUY
Tech 62.0 Fund 44.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 54
RSI-14: 54.4 · SMA20: $22.82 · SMA50: $24.18
CBAN NYSE
Colony Bankcorp Inc.
State Commercial Banks
$20.18
-0.79% 1D
Market Cap $555.2M
TTM Revenue $154M
Forward P/E 8.4x
Beta / 30D Vol 0.37β · 20% Vol
Unified Composite Score
44.9 / 100 HOLD
Tech 47.0 Fund 46.0 Flow 50.0 Mom 39.2
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.5%) with fading momentum, RSI 47
RSI-14: 46.8 · SMA20: $20.30 · SMA50: $20.46

6-Pillar Scorecard Institutional Category Breakdown (HFBL 1 – 4 CBAN)

Columns: Metric · HFBL · CBAN
1. Valuation Multiples CBAN
Forward P/E 11.8x 8.4x
Trailing P/E 11.3x 11.2x
PEG Ratio N/M 2.11x
EV / Revenue 2.9x 3.6x
2. Growth & Scale CBAN
Revenue Growth (YoY) +10.5% +26.0%
Earnings Growth (YoY) +19.2% +50.2%
TTM Revenue (USD) $24M $154M
Market Cap $71.8M $555.2M
3. Profitability & Quality HFBL
Gross Margin 100.0% 100.0%
Operating Margin 37.1% 33.4%
Net Profit Margin 26.5% 24.3%
Return on Equity (ROE) 11.2% 10.8%
4. Balance Sheet & Cash Flow CBAN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $19.69 Book/Sh · 11.2% ROE $18.46 Book/Sh · 10.8% ROE
Dividend Yield 1.81% 2.34%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 594.7% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat CBAN
OpEx & R&D Intensity 62.9% of Rev ($15M) 66.6% of Rev ($102M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HFBL (5) vs CBAN (5)
Institutional Metric HFBL CBAN Criterion Row Edge
Market Capitalization
Scale
$71.8M $555.2M Larger Scale CBAN
Trailing P/E Ratio
Valuation
11.3x 11.2x Lower Multiple CBAN
Forward P/E Ratio
Valuation
11.8x 8.4x Lower Multiple CBAN
Revenue Growth (YoY)
Growth
+10.5% +26.0% Higher Growth CBAN
Operating Margin (TTM)
Profitability
37.1% 33.4% Higher Margin HFBL
Net Profit Margin
Profitability
26.5% 24.3% Higher Margin HFBL
Return on Equity (ROE)
Capital Efficiency
11.2% 10.8% Higher ROE HFBL
52-Week Range Position
Momentum
75% ($13–$28) 65% ($16–$22) Stronger Trend HFBL
Beta / 30D Volatility
Risk Regime
0.00β · 81% Vol 0.37β · 20% Vol Lower Realized Risk CBAN
Unified Institutional Score
Composite Signal
61.3 / 100 (BUY) 44.9 / 100 (HOLD) Higher Composite HFBL
Trailing 12M Revenue (USD)
Operating Scale
$24M $154M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.9x EV/Rev 2.11x PEG · 3.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($19.69 Book/Sh · 11.2% ROE) N/A ($18.46 Book/Sh · 10.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HFBL +1.25 pp
HFBL: +0.12% · CBAN: -1.13%
3M Horizon HFBL +11.93 pp
HFBL: +6.1% · CBAN: -5.83%
6M Horizon HFBL +32.62 pp
HFBL: +38.39% · CBAN: +5.77%
1Y Horizon HFBL +36.02 pp
HFBL: +58.62% · CBAN: +22.6%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HFBL vs CBAN. Trailing 12-month operating profitability (HFBL 37.1% vs CBAN 33.4%) and valuation multiples (HFBL 11.8x vs CBAN 8.4x Forward P/E) are benchmarked directly in Pillar 4 below.

HFBL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$24M
Gross Margin100.0%
Op. Margin37.1%
ROE / Fwd P/E11.2% · 11.8x
CBAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$154M
Gross Margin100.0%
Op. Margin33.4%
ROE / Fwd P/E10.8% · 8.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HFBL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HFBL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CBAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 594.7%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CBAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HFBL Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $71.8M market capitalization and 37.1% operating margin.
OpEx & R&D Reinvestment 62.9% of Rev ($15M)
90D Engineering Disclosures 0 Published
CBAN Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $555.2M market capitalization and 33.4% operating margin.
OpEx & R&D Reinvestment 66.6% of Rev ($102M)
90D Engineering Disclosures 0 Published

Investor FAQ HFBL vs CBAN Key Questions & Quantitative Answers

As of Nov 16, 2026, Home Federal Bancorp, Inc. of Louisiana (HFBL) captures the overall head-to-head institutional edge over Colony Bankcorp Inc. (CBAN) on higher Unified Composite conviction (61.3/100 BUY vs. 44.9/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality), while CBAN wins 4–1 across the 6-pillar growth and valuation breakdown. HFBL trades at $24.19 (11.8x Forward P/E, 37.1% operating margin) versus CBAN at $20.18 (8.4x Forward P/E, 33.4% operating margin). Growth vs. Quality Trade-Off: HFBL earns the overall head-to-head edge with a stronger Unified Composite Score (61.3/100 BUY vs. CBAN 44.9/100 HOLD) and 0.00β · 81% Vol risk profile, whereas CBAN leads top-line expansion (+26.0% YoY revenue growth, 2.11x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: HFBL trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.4); meanwhile CBAN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CBAN leads the Growth & Scale pillar: HFBL posts +10.5% YoY revenue growth and +19.2% YoY earnings growth on $24M TTM revenue (100.0% gross margin, 37.1% operating margin), compared with CBAN at +26.0% YoY revenue growth and +50.2% YoY earnings growth on $154M TTM revenue (100.0% gross margin, 33.4% operating margin). On trailing 12-month operating scale, HFBL generates $24M in USD-normalized revenue versus $154M for CBAN. In operating R&D and SG&A reinvestment, HFBL deploys 62.9% of Rev ($15M) (0 90-day corporate R&D disclosures) versus 66.6% of Rev ($102M) (0 disclosures) for CBAN.

CBAN screens cheaper on headline valuation multiples. HFBL trades at 11.8x Forward P/E, 11.3x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (unreported cash flow margin), whereas CBAN trades at 8.4x Forward P/E, 11.2x Trailing P/E, 2.11x PEG, and 3.6x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HFBL (11.2% ROE) versus CBAN (10.8% ROE) capital efficiency.

In options market volatility and institutional positioning, HFBL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 81% Vol realized risk). By comparison, CBAN carries 594.7% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.